229 related articles for article (PubMed ID: 16795967)
1. Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.
Ishigami S; Natsugoe S; Nakashima H; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Nakashima S; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(69):338-41. PubMed ID: 16795967
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody.
Takahashi Y; Ohta T; Mai M
Oncol Rep; 2004 Apr; 11(4):809-13. PubMed ID: 15010877
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.
Inoue M; Sano T; Kuchiba A; Taniguchi H; Fukagawa T; Katai H
Br J Surg; 2010 Jul; 97(7):1056-61. PubMed ID: 20632272
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
Chang YC; Nagasue N; Abe S; Taniura H; Kumar DD; Nakamura T
Am J Gastroenterol; 1992 Mar; 87(3):321-5. PubMed ID: 1371637
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases.
Liu X; Cheng Y; Sheng W; Lu H; Xu Y; Long Z; Zhu H; Wang Y
J Surg Oncol; 2010 Sep; 102(3):249-55. PubMed ID: 20740583
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
Ucar E; Semerci E; Ustun H; Yetim T; Huzmeli C; Gullu M
Adv Ther; 2008 Oct; 25(10):1075-84. PubMed ID: 18821070
[TBL] [Abstract][Full Text] [Related]
7. [The characters of AFP-producing early gastric cancer].
Chang YC; Nagasue N; Abe S; Kohno H; Yamanoi A; Uchida M; Nakamura T
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1574-80. PubMed ID: 1702182
[TBL] [Abstract][Full Text] [Related]
8. Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.
Uefuji K; Ichikura T; Tamakuma S
Jpn J Clin Oncol; 1994 Jun; 24(3):135-40. PubMed ID: 7516444
[TBL] [Abstract][Full Text] [Related]
9. High CD40 expression in gastric cancer associated with expanding type histology and liver metastasis.
Lo SS; Wu CW; Chi CW; Li AF; Chen JH; Lui WY
Hepatogastroenterology; 2005; 52(66):1902-4. PubMed ID: 16334803
[TBL] [Abstract][Full Text] [Related]
10. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
11. [Effective transcatheter arterial embolization for hepatic metastasis in a case of AFP producing gastric cancer].
Kobayashi T; Hirose K; Niimoto S; Katayama K; Yamaguchi A; Nakagawara G
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1705-8. PubMed ID: 8886049
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CCR7 expression in gastric cancer.
Ishigami S; Natsugoe S; Nakajo A; Tokuda K; Uenosono Y; Arigami T; Matsumoto M; Okumura H; Hokita S; Aikou T
Hepatogastroenterology; 2007 Jun; 54(76):1025-8. PubMed ID: 17629031
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues.
Choi MG; Sohn TS; Park SB; Paik YH; Noh JH; Kim KM; Park CK; Kim S
Eur Surg Res; 2009; 42(4):223-9. PubMed ID: 19279387
[TBL] [Abstract][Full Text] [Related]
16. A rare case of alpha-fetoprotein-producing early gastric cancer.
Shimoyama S; Nozaki K; Kaminishi M; Motoi N; Murakami T
Hepatogastroenterology; 2001; 48(39):687-91. PubMed ID: 11462904
[TBL] [Abstract][Full Text] [Related]
17. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
18. [A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with EAP (etoposide, adriamycin, cisplatin) therapy].
Gonda T; Ishida H; Higuchi T; Hirukawa H; Nakajima H; Hojo I; Mishima Y
Gan To Kagaku Ryoho; 1994 Aug; 21(10):1659-63. PubMed ID: 7520221
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer.
Chang YC; Nagasue N; Kohno H; Taniura H; Uchida M; Yamanoi A; Kimoto T; Nakamura T
Am J Gastroenterol; 1990 Nov; 85(11):1480-5. PubMed ID: 1700600
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
Liu X; Yu H; Cai H; Wang Y
J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
